Yukitoshi Satoh Selected Research

Neuroblastoma

1/2019	A case report of a thymic neuroblastoma associated with syndrome of inappropriate secretion of antidiuretic hormone: Ten-year follow-up results after surgical treatment.
11/2009	Thymic neuroblastoma with the syndrome of inappropriate secretion of antidiuretic hormone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukitoshi Satoh Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 02/2005
24	Adenocarcinoma of Lung 01/2022 - 04/2004
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 12/2005
19	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2008
16	Adenocarcinoma 01/2022 - 04/2004
12	Carcinoma (Carcinomatosis) 01/2019 - 12/2007
11	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 01/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2012 - 03/2008
4	Thymoma (Thymic Carcinoma) 01/2021 - 11/2009
3	Lymphatic Metastasis 01/2022 - 04/2011
3	Hemorrhage 09/2020 - 11/2013
3	Small Cell Carcinoma 01/2015 - 01/2008
2	Postoperative Hemorrhage 04/2020 - 03/2018
2	Inappropriate ADH Syndrome (SIADH) 01/2019 - 11/2009
2	Neuroblastoma 01/2019 - 11/2009
2	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 05/2005
2	Meningioma (Meningiomas) 01/2017 - 03/2010
2	Hematoma 01/2017 - 11/2013
2	Lewis Lung Carcinoma 02/2014 - 12/2009
1	Lymphoma (Lymphomas) 05/2020
1	Fibrosis (Cirrhosis) 09/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2019
1	Empyema 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 06/2018
1	Myasthenia Gravis 03/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2007
6	Biological ProductsIBA 11/2019 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2005
4	PlatinumIBA 01/2020 - 01/2011
4	AutoantibodiesIBA 01/2020 - 06/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2019 - 10/2008
4	Formaldehyde (Formol)FDA Link 12/2018 - 02/2010
4	Monoclonal AntibodiesIBA 04/2018 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2010
3	Anaplastic Lymphoma KinaseIBA 01/2019 - 01/2008
3	Indicators and Reagents (Reagents)IBA 04/2018 - 01/2007
3	AntigensIBA 04/2018 - 01/2012
3	VimentinIBA 01/2018 - 04/2015
3	Carcinoembryonic AntigenIBA 08/2017 - 10/2008
3	NestinIBA 01/2017 - 04/2011
3	Messenger RNA (mRNA)IBA 12/2012 - 01/2008
3	Phosphotransferases (Kinase)IBA 02/2012 - 10/2008
3	ParaffinIBA 12/2011 - 02/2010
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 12/2018
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021 - 01/2021
2	Vasopressins (Vasopressin)IBA 01/2019 - 11/2009
2	SolutionsIBA 12/2018 - 02/2014
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 12/2011
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 11/2011
2	RNA (Ribonucleic Acid)IBA 01/2017 - 10/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2014 - 12/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 12/2009
2	AntibodiesIBA 06/2012 - 05/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012 - 12/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 10/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2010 - 03/2008
2	Protein Isoforms (Isoforms)IBA 05/2009 - 10/2008
2	Gemcitabine FDA Link 03/2008 - 02/2005
1	Galectin 3 (LGALS3)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	nafamostatIBA 09/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2020
1	Protein Kinases (Protein Kinase)IBA 05/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 11/2019
1	indium-bleomycinIBA 09/2019
1	Collagen Type I (Type I Collagen)IBA 09/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2019
1	MucinsIBA 07/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	SuspensionsIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 12/2018
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Prednisone (Sone)FDA LinkGeneric 03/2018
1	C-Reactive ProteinIBA 03/2018
1	Cholinergic ReceptorsIBA 03/2018

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 11/2020 - 02/2005
5	Adjuvant Chemotherapy 01/2020 - 02/2005
4	Therapeutics 01/2022 - 11/2011
4	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2007
4	Thymectomy 01/2021 - 11/2009
3	Operative Surgical Procedures 02/2022 - 12/2018
3	Length of Stay 04/2020 - 05/2013
2	Aftercare (After-Treatment) 01/2022 - 11/2020
2	Immunotherapy 01/2018 - 01/2017
2	Thoracotomy 11/2013 - 05/2013
2	Molecular Targeted Therapy 02/2012 - 11/2011
1	Renal Dialysis (Hemodialysis) 09/2020
1	Operative Time 04/2020
1	Robotic Surgical Procedures 04/2020
1	Esophagectomy 06/2018
1	Sternotomy 03/2018
1	Drug Tapering 03/2018
1	Activities of Daily Living (ADL) 03/2018